However, patients with established metabolic syndrome, cardiometabolic disorders, and/or T2DM exhibit elevated circulating IL-22 levels, potentially as a compensatory response (Asadikaram et al., 2018; Gong et al., 2016; Gu et al., 2022). Here, IL22 is linked to type 2 diabetes mellitus.